research use only
Cat.No.S4116
| Related Targets | HSP Transferase P450 (e.g. CYP17) PDE phosphatase PPAR Vitamin Carbohydrate Metabolism Mitochondrial Metabolism Drug Metabolite |
|---|---|
| Other Dehydrogenase Inhibitors | Vorasidenib (AG-881) (R)-GNE-140 CPI-613 (Devimistat) Sodium Dichloroacetate (DCA) Gossypol Acetate AGI-5198 AGI-6780 Emodin NCT-503 Brequinar |
|
In vitro |
DMSO
: 20 mg/mL
(197.72 mM)
Water : 20 mg/mL Ethanol : 20 mg/mL |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 101.15 | Formula | C5H11NO |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 541-46-8 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | 3-Methylbutanamide | Smiles | CC(C)CC(=O)N | ||
| Targets/IC50/Ki |
alcohol dehydrogenase
|
|---|---|
| In vitro |
Isovaleramide is isolated from the most active fraction of Valeriana pavonii. This compound (300 µM) exhibits a 42% of inhibition of the binding of ³H-FNZ to its sites in the in vitro assay. It is without effect at concentrations up to 1000 μM in a variety of in vitro neurotransmitter binding or uptake assays, suggesting that its action does not involve a direct receptor-mediated effect at those systems studied. This chemical (0.15%) induces the formation of nitrile hydratase in Rhodococcus sp. YH 3-3. |
| In vivo |
Isovaleramide (100 mg/Kg, p.o) evidences a 90% index protection against the maximal electroshock seizure in mice (MES). This compound produces a consistent pattern of signs at relatively high doses in extensive safety studies in rats, rabbits, and dogs. It shows a significantly lower potential for reproductive toxicity than VPA in several reproductive toxicity studies conducted in mice, rats and rabbits. |
References |
|
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.